News Pfizer's haemophilia B gene therapy meets phase 3 primary en... As December 2022 closed out, Pfizer announced positive top-
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
